This neuroprotective effect was partially reversed by a specific inhibitor of protein kinase G (PKG), suggesting that the effect of CORM-3 on improving depression and anxiety-like performance is related to the PKG-extracellular signal-regulated kinase 1/2 signaling pathway (Li Y. et al., 2020). Here, PRKG1 is linked to depressive symptom measurement.